author-photo

Stephen R. Marder

University of California, Los Angeles
Semel Institute for Neuroscience and Human Behavior
West Los Angeles College

454

Papers

28766

Citations

Citation Trend

Filter By

Papers (453) Sort By

Journal Conference Others

Review for "Monitoring for Myocarditis during Treatment Initiation with Clozapine"

2021
- Stephen R. Marder
Show All
- Source
- Cite
- Save
Citations (0)
Onset and Resolution of Key Adverse Events in Valbenazine-Treated Patients with Tardive Dyskinesia: Pooled Analyses from Two Long-Term Clinical Trials

2021 Cns Spectrums
Show All
- Source
- Cite
- Save
Citations (0)
Changing the Face of Schizophrenia.

2021 American Journal of Psychiatry
- Stephen R. Marder
Show All
- Source
- Cite
- Save
Citations (0)
Effects of Brexpiprazole Across Symptom Domains in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies

2021
Show All
- Source
- Cite
- Save
Citations (0)
PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients.

2021 The Journal of Clinical Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
Antipsychotic discontinuation and recovery: chicken or egg?

2021 Psychological Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers.

2020 Neuropsychopharmacology
Show All
- Source
- Cite
- Save
Citations (14)
Issues and Perspectives in Designing Clinical Trials for Negative Symptoms in Schizophrenia: Consensus Statements

2020
Show All
- Source
- Cite
- Save
Citations (1)
The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research

2020
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Efficacy and Target Engagement of Glutamatergic Drugs: Placebo-Controlled RCTs of Pomaglumetad and TS-134 for Reversal of Ketamine-Induced Psychotic Symptoms and PharmacoBOLD in Healthy Volunteers

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (4)